Todos os estudos
AutorizadoFarmacologia Humana (Fase I) - Primeira administração em humanosIntervencionista

A Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Phase 1 Study of CMP-CPS-001 in Healthy Volunteers and Participants with Abnormal Heterozygous Ornithine Transcarbamylase (OTC) Genotype

This is a very early study looking at a new potential medicine called CMP-CPS-001. It's designed for people with urea cycle disorders, which are rare genetic conditions where the body has trouble getting rid of waste products properly. The main goal of this study is to check the safety of CMP-CPS-001 and see how it behaves in the body. Researchers will give different doses to healthy volunteers and people who have a specific genetic change linked to urea cycle disorder, even if they don't have symptoms. This helps them understand if the medicine is safe and how it might work before more advanced studies can happen. It's the first time this medicine is being given to humans.

Em resumo

Status
Autorizado
Fase
Farmacologia Humana (Fase I) - Primeira administração em humanos
Patrocinador
Camp4 Therapeutics Corp.
Meta de inscrição
12
Iniciar
09 Aug 2025

Sobre o que é este estudo?

This study is about a new medicine, CMP-CPS-001, for a group of rare genetic conditions called urea cycle disorders (UCDs). Our bodies naturally produce waste products, and UCDs mean the body struggles to break down a specific waste product called ammonia. Too much ammonia can be harmful. This new medicine aims to help the body process these waste products more effectively.

This is a 'Phase 1' study, which means it's one of the very first times this medicine is being tested in people. The main focus is to make sure the medicine is safe and to understand how it acts in the human body. Researchers will check for any side effects and how the medicine is absorbed, used, and cleared from the body. Because it's an early study, participants include healthy volunteers and people who have inherited a genetic change that can cause urea cycle disorder, even if they don't currently have symptoms.

The study involves giving participants either the new medicine or a dummy medicine (called a placebo) without them knowing which they receive. This helps researchers compare the effects accurately. Understanding the safety and initial effects of CMP-CPS-001 in this early stage is a crucial step towards potentially developing a new treatment for urea cycle disorders in the future.

Pontos principais

  • This is an early-stage study checking safety and how a new medicine (CMP-CPS-001) works.
  • It's for people with urea cycle disorders or specific genetic changes linked to them.
  • Participants will receive either the study medicine or a dummy medicine (placebo).
  • Close medical checks and monitoring will happen throughout the study.
  • Your participation helps advance research for rare conditions.
  • Você pode deixar o estudo a qualquer momento se mudar de ideia.

Quem pode ser elegível?

To join this study, you need to be an adult, aged 18 or older. Both men and women can take part.

The study is looking for two groups of people: healthy volunteers and people who have a specific genetic change related to urea cycle disorders, even if they feel well and don't have symptoms right now. This genetic change is found when doctors check your genes.

There might be other health checks or requirements that the study doctors will discuss with you to make sure it's safe for you to participate.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Are you male or female?
  3. Have you been told you have a specific inherited genetic change related to urea cycle disorders (even if you're healthy)? OR Are you a healthy volunteer?
  4. Você consegue comparecer às consultas na clínica de estudos?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to take part, you will be given either the study medicine (CMP-CPS-001) or a placebo (a dummy medicine) through a drip into your arm. You won't know which one you're getting because it's a 'double-blind' study. You will have several clinic visits over a period of time. These visits will involve various checks to monitor your health and how your body reacts to the medicine.

These checks typically include keeping an eye on your vital signs (like heart rate and blood pressure), doing electrical heart tests (ECGs), taking blood and urine samples for lab tests, and having physical examinations. You may also be asked to undergo specific tests to see how your body processes certain substances. The total time you'd be involved in the study, including follow-up, will be explained by the study team.

Riscos e benefícios potenciais

Participating in research studies like this helps advance medical knowledge and could lead to new treatments for urea cycle disorders. While there's no guarantee this new medicine will directly benefit you, you'll receive careful medical supervision. However, like all medicines, CMP-CPS-001 might have side effects, and some may be unexpected. The study team will explain all known or potential risks to you. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Localizações (1)

Algumas localizações dos sites são aproximadas. Estamos melhorando isso — por favor, verifique com a equipe de teste antes de viajar.
  • —
    Não verificado
    Países Baixos

Perguntas frequentes

What are urea cycle disorders (UCDs)?

UCDs are rare conditions where the body can't remove harmful waste products (like ammonia) properly, which can be bad for your health.

O que significa 'estudo de Fase 1'?

It's an early study, mainly focused on checking if a new medicine is safe for people and how it works in the body for the first time.

Will I know if I'm getting the real medicine or a dummy one?

No, this is a 'double-blind' study, meaning neither you nor the study team will know which you receive until after the study is over.

Why include healthy people and those with a genetic change?

Comparing how the medicine works in both groups helps researchers understand its effects better and prepare for future studies in people with symptoms.

How long will I be involved if I join?

The total duration of your participation, including visits and follow-up, will be clearly explained by the study team before you decide.

Como saber mais

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.